Deep Margin
Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium
39:56
Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.